Vaccine

GC376, the Primary Component of Anivive’s Feline Infectious Peritonitis Drug, Nominated by AVMA and FelineVMA to FDA’s List of Bulk Drug Substance for Compounding Office Stock

Nomination could expedite GC376 availability for veterinariansBlack market FIP treatments shown to be unpredictable and dangerousOther organizations are encouraged to...

Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM’s Ampligen® and AstraZeneca’s FluMist® to address the recent avian influenza outbreaks

Planned Investigational New Drug application to expand on previous clinical work at the University of Alabama-Birmingham in which administration of...

IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate

– Submission of Investigational New Drug Application (IND) to US FDA expected in 2025 – NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE)...

Medidata Advances New Frontiers for Life Sciences Through Patient-Centric Experiences, AI-Powered Innovations, and New Patient Engaging Alliances

In the era of the generative economy, Medidata is transforming how industries are empowering patients with new cure and care...

error: Content is protected !!